Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Neuromodulation Stories

2013-06-13 08:27:38

LONDON, June 13, 2013 /PRNewswire/ -- A recent study, by Silchenko et al. (Neuroimage 2013)* has revealed that evidence-based tinnitus treatment - Acoustic CR(R) Neuromodulation - can reduce symptoms by normalizing interactions between different brain areas. In responding patients - after only 12 week's treatment - interactions within tinnitus-related areas were no longer distinguishable from those observed in healthy individuals. As a result, the tinnitus was 'silenced'....

2013-04-28 23:02:09

[193 Pages Report] Neuromodulation market report categorizes the global market on the basis of (Spinal Cord, Vagus Nerve, Deep Brain, Sacral Nerve & Transcranial Magnetic) Stimulation by procedure, technology and application forecasting 2012 - 2017. (PRWEB) April 28, 2013 Neuromodulation Market — [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial...

2013-04-12 08:25:31

World's First and Only System with Illumina 3D(TM) Software and 32 Contacts is Designed to Provide Pain Relief to a Broad Spectrum of Chronic Pain Patients NATICK, Mass., April 12, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received approval by the U.S. Food and Drug Administration and is beginning a limited launch of the Precision Spectra Spinal Cord Stimulator (SCS) System. The Precision Spectra System is the world's first and only SCS system with Illumina...

2013-03-25 12:27:11

DUBLIN, March 25, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/t8zp6f/neuromodulation) has announced the addition of the "Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017" report to their offering. (Logo:...

2013-02-22 23:01:23

Research and Markets announces the addition of "Neuromodulation Market — [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), & Transcranial Magnetic Stimulation (TMS)] — Forecasts to 2017" to its catalogue. (PRWEB) February 22, 2013 Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market due to high demand for...

2013-02-13 08:28:47

HOUSTON, Feb. 13, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences. Dan Moore, Cyberonics' President & Chief Executive Officer, will participate in the neuromodulation panel discussion at the Citi 2013 Global Healthcare Conference in New York on Wednesday, February 27, 2013 at 11:05 AM Eastern Time. This panel discussion will not be...

2013-02-04 12:25:52

HOUSTON, Feb. 4, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the lawsuit filed by former employee Andrew Hagerty in federal district court in Massachusetts was voluntarily dismissed without prejudice by Mr. Hagerty on February 1, 2013. The company has asserted that, under the terms of his employment, Mr. Hagerty's claims are subject to binding arbitration. Mr. Hagerty has the right to re-file the lawsuit or to pursue a resolution through binding...

2013-01-28 23:01:06

[193 Pages Report] Neuromodulation devices market report categorizes the global market of Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation & Trans-cranial Magnetic Stimulation by procedure, technology, and application. (PRWEB) January 28, 2013 The “Neuromodulation Market — [Spinal Cord Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation & Trans-cranial...

2013-01-14 02:29:16

DALLAS, January 14, 2013 /PRNewswire/ -- The "Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, APAC, and Rest of the World. Browse market 93 data tables, 4 figures...

2012-12-07 04:21:02

NATICK, Mass., Dec. 7, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval and has begun the European market launch of the Precision Spectra(TM) Spinal Cord Stimulator (SCS) System. The Precision Spectra System is the world's first and only SCS system with 32 contacts and 32 dedicated power sources and is designed to provide improved pain relief to a wide range of patients who suffer from chronic pain. The first commercial implant of the Precision...